CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)
Part of paid clinical trials in Columbia, Missouri.
- Sponsor
- University of Missouri-Columbia
- Study ID
- NCT05846399
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Anti-bacterial Agents
- Arm Injury
- Cat Bite
- Hand Injuries
- Infection, Bacterial
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Amoxicillin/clavulanate — DRUGAmoxicillin-clavulanate 875-125mg by mouth twice daily for 1 day or Ciprofloxacin 500mg by mouth twice daily and clindamycin 450mg by mouth twice daily for 1 day
- Ciprofloxacin — DRUGAmoxicillin-clavulanate 875-125mg by mouth twice daily for 5 days or Ciprofloxacin 500mg by mouth twice daily and clindamycin 450mg by mouth twice daily for 5 days
- Clindamycin — DRUGAmoxicillin-clavulanate 875-125mg by mouth twice daily for 5 days or Ciprofloxacin 500mg by mouth twice daily and clindamycin 450mg by mouth twice daily for 5 days
- Placebo (microcrystalline cellulose) — OTHERPlacebo (microcrystalline cellulose) by mouth twice daily by mouth for 5 days
- Wound management — PROCEDUREWound management includes hemostasis, copious irrigation, removal of foreign bodies, and excisional debridement of devitalized tissue. If only punctures are present, lancing of the punctures is not typically required unless infection has already developed. Local anesthesia (1% lidocaine hydrogen chloride (HCl) with epinephrine 1:100,000; 200mg/20mL vial) will be used prior to irrigation (30mL of povidone-iodine in 1L of 0.9% sodium chloride (NaCl) solution and/or 118mL of 3% hydrogen peroxide) and debridement. Open wounds will be irrigated and debrided at bedside. Wounds will be covered with soft dressings in place until first follow-up at day 2.
Study Details
Cat bites are puncture wounds that have the potential to seed bacteria deep within the joint capsule, periosteum, and bone. The hand is the most common site of bite injuries. Pasteurella multocida is the is the most common organism isolated from the mouths of cats that can cause infections after a bite. Prophylactic antibiotics are often recommended with amoxicillin-clavulanate for 3-5 days to decrease the incidence of developing an infection. However, only one randomized controlled clinical trial consisting of 12 patients has been performed to justify this course of treatment, raising the possibility that the use of antibiotics could be reduced or even eliminated. Investigators will compare different durations of prophylactic antibiotics and a placebo control for cat bites to the hand/forearm presenting to the Emergency Department, Urgent Care, Plastic Surgery Clinic using a randomized, controlled, double-blind clinical trial. Participants presenting to the University of Missouri Hospital Emergency Department, Missouri University (MU) Healthcare Urgent Care, Plastic Surgery Clinic over the next year will be offered the chance to enroll if they meet the inclusion/exclusion criteria. For inclusion, participants will be \>18 years of age, have cat bites to the hand or distal to elbow, and present within 24 hours of the cat bite injury. Participants must not present with active local or systemic infections, have received antibiotics within the past 30 days, or be immunocompromised (primary and secondary immunodeficiencies). Participants will be randomized to one of three treatment arms (placebo; amoxicillin-clavulanate 1 day; amoxicillin-clavulanate 5 days). Outcomes are the development of an infection at the location of the cat bite and/or systemic infection, adverse effects of interventions, disability assessed by Quick Disabilities of Arm, Shoulder and Hand (QuickDASH) scores, and quality of life (QOL) assessed by HAND Questionnaire (HAND-Q) scores. Infection will be assessed at day 0, day 2, day 7+/-2, day 14+/-2, and day 30+/-2 by vital signs, laboratory values, physical examination and with an infrared and digital camera. All measures will be within the standard of care, apart from the infrared camera, QuickDASH, and HAND-Q scores. The anatomic locations of cat bites to the hand/forearm will be assessed for correlations with infections.
Key Dates
- Start date
- Sep 7, 2023
- Status verified
- Oct 2025
- Primary completion
- Jul 1, 2027
- Completion
- Aug 1, 2027
Study Design
- Enrollment
- 72 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Placebo Comparator: Placebo (microcrystalline cellulose)Placebo capsules by mouth twice daily x 5 days (5 days of placebo microcrystalline cellulose capsules)
- Active Comparator: Antibiotic x 1 dayAmoxicillin-clavulanate 875-125mg capsules by mouth twice daily x 1 day (4 days of placebo capsules) -Penicillin allergy: ciprofloxacin 500mg by mouth twice daily + clindamycin 300mg by mouth three times daily x 1 day
- Active Comparator: Antibiotic x 5 daysAmoxicillin-clavulanate 875-125mg capsules by mouth twice daily x 5 days (0 days of placebo capsules) -Penicillin allergy: ciprofloxacin 500mg by mouth twice daily + clindamycin 300mg by mouth three times daily x 5 days
Primary Outcome Measure
Incidence of infection [ Time Frame: Day 30+/-2 ]
Central Contacts
- Stephen H Colbert, MD573-882-2277
- Kevin M Klifto, DO, PharmD573-882-2277
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Missouri | Columbia | Missouri | 65212 |
Find similar trials in Columbia, MO
Related Studies
- Human Upper Extremity AllotransplantationPHASE2 · Recruiting · Johns Hopkins University · Baltimore, Maryland
- Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?Recruiting · Michigan State University · Lansing, Michigan
- Human Upper Extremity Allotransplantation: F/U ProtocolRecruiting · Johns Hopkins University · Baltimore, Maryland
- Craniomaxillofacial and Upper Extremity AllotransplantationRecruiting · NYU Langone Health · New York, New York